Economic burden of multiple myeloma among patients in successive lines of therapy in the United States
Author:
Affiliation:
1. Precision Health Economics, Los Angeles, CA, USA;
2. Wake Forest Baptist Medical Center, Winston-Salem, NC, USA;
3. University of California, Los Angeles, Los Angeles, CA, USA;
4. Bristol-Myers Squibb, Princeton, NJ, USA
Funder
Bristol-Myers Squibb
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1361035
Reference34 articles.
1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
2. Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management
3. European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
4. Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
5. Treatment of multiple myeloma
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The results of therapy of patients with multiple myeloma in real clinical practice (results of a multicenter study);Meditsinskiy sovet = Medical Council;2024-01-19
2. Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study;Cancers;2023-11-09
3. Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study;Clinical Lymphoma Myeloma and Leukemia;2023-10
4. Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022;Healthcare;2023-08-11
5. Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis;Journal of Managed Care & Specialty Pharmacy;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3